Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)

Priya Rastogi, D. Lawrence Wickerham, Charles E. Geyer, Eleftherios P. Mamounas, Thomas B. Julian, Norman Wolmark

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.

Original languageEnglish (US)
Article number7
JournalChinese Clinical Oncology
Issue number1
StatePublished - 2017


  • Breast cancer
  • Clinical trials
  • Locoregional therapy for breast cancer
  • Systemic therapy for breast cancer

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)'. Together they form a unique fingerprint.

Cite this